Alkylating agents in bronchogenic carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy* / Q000401:mortality; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002699:Chlorambucil / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage
D000477:Alkylating Agents; D009588:Nitrogen Mustard Compounds; D002699:Chlorambucil; D003520:Cyclophosphamide